statistiche ricercatore

Nome	#
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.	115
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment	99
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.	74
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.	74
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications.	74
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients	74
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.	65
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor	65
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.	61
Totale	701

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	79	0	0	0	0	6	5	16	7	3	22	18	2
2020/2021	55	10	3	11	0	3	12	0	0	5	7	0	4
2021/2022	52	1	2	1	12	0	2	0	1	4	9	6	14
2022/2023	166	15	29	14	18	14	28	8	6	23	2	7	2
2023/2024	90	4	2	7	3	6	23	23	7	0	3	1	11
2024/2025	71	9	25	29	5	3	0	0	0	0	0	0	0
Totale													701